University at Buffalo researcher Chris (Chunhao) Li, assistant professor of oral biology in the School of Dental Medicine, has been awarded a $1.6 million research grant from the National Institutes of Health to develop processes, possibly leading to therapeutic compounds, which prevent biofilm formation of oral bacteria.
Li’s quest to develop these processes begins with bacterial quorum sensing systems that play a very important role in the formation and development of biofilm in numerous bacterial species, including oral bacteria.
“Quorum sensing is a type of bacterial cell-to-cell communication — a kind of decision-making process — and it is achieved through the production, release and detection of small signaling molecules called autoinducers (AIs),” said Li.
AIs come in two types and one of them has become the object of Li’s research. AI-2’s key biosynthesis enzyme is LuxS — whose quorum-sensing systems regulate a diverse group of activities in bacteria, including biofilm formation, and may be a potential molecular target for developing a novel class of therapeutic agents.
By defining the biochemical characteristics of LuxS proteins, Li hopes to identify compounds that are able to inhibit the biofilm formation of pathogenic oral bacteria.
The NIH-funded research may lead to better understanding of the biochemical features of LuxS proteins in oral bacteria, potentially creating new ways to prevent and treat oral microbial infections.
The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB’s more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.